Clazosentan Affects Temporal Profile of Endothelin-A Expression in Macro- and Microcirculation after Subarachnoid Hemorrhage

Subarachnoid hemorrhage is a life-threatening cerebrovascular event, and cerebral vasospasm remains a major cause of poor neurological outcomes. Clazosentan, an endothelin-A receptor antagonist, has been recently approved in Japan to reduce post-subarachnoid hemorrhage vasospasm; however, recurrent...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yuyuan ZHENG, Masahito KAWABORI, Yoichiro FUJIOKA, Shuho GOTOH, Ryota TATEZAWA, Takuma IKEDA, Taishi HONDA, Yo NAKAHARA, Erika YOSHIE, Zheng LI, Yusuke OHBA, Miki FUJIMURA
Format:	Artigo
Jezik:	Inglês
Izdano:	The Japan Neurosurgical Society 2026-02-01
Serija:	Neurologia Medico-Chirurgica
Teme:	subarachnoid hemorrhage vasospasm clazosentan endothelin-a receptor pericyte
Online pristup:	https://www.jstage.jst.go.jp/article/nmc/66/2/66_2025-0185/_pdf/-char/en
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!